AAAAAA

   
Results: 1-9 |
Results: 9
CHEMOTHERAPY IMMEDIATELY FOLLOWING AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH ADVANCED BREAST-CANCER
Authors: RAHMAN Z KAVANAGH J CHAMPLIN R GILES R HANANIA E FU SQ ZU ZF MEHRA R HOLMES F KUDELKA A CLAXTON D VERSCHRAEGEN C GAJEWSKI J ANDREEFF M HEIMFELD S BERENSON R ELLERSON D CALVERT L MECHETNER E HOLZMAYER T DAYNE A HAMER J BACHIER C OSTROVE J PRZEPIORKA D BURTNESS B COTE R BAST R HORTOBAGYI G DEISSEROTH A
Citation: Z. Rahman et al., CHEMOTHERAPY IMMEDIATELY FOLLOWING AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH ADVANCED BREAST-CANCER, Clinical cancer research, 4(11), 1998, pp. 2717-2721
IDENTIFICATION OF CELLULAR GENES SUPPORTING THE HIV-1 LIFE-CYCLE
Authors: DUNN S SHARMA V PARK S SIMONE J ENGELKE U TAVASSOLI R ORTEGA M LIPKINA G DAYN A HOLZMAYER T
Citation: S. Dunn et al., IDENTIFICATION OF CELLULAR GENES SUPPORTING THE HIV-1 LIFE-CYCLE, The FASEB journal, 11(9), 1997, pp. 736-736
EVALUATION OF NEWER PROGNOSTIC MARKERS FOR ADULT SOFT-TISSUE SARCOMAS
Authors: LEVINE EA HOLZMAYER T BACUS S MECHETNER E MERA R BOLLIGER C RONINSON IB DASGUPTA TK
Citation: Ea. Levine et al., EVALUATION OF NEWER PROGNOSTIC MARKERS FOR ADULT SOFT-TISSUE SARCOMAS, Journal of clinical oncology, 15(10), 1997, pp. 3249-3257
RESULTS OF MDR-1 VECTOR MODIFICATION TRIAL INDICATE THAT GRANULOCYTE MACROPHAGE COLONY-FORMING UNIT CELLS DO NOT CONTRIBUTE TO POSTTRANSPLANT HEMATOPOIETIC RECOVERY FOLLOWING INTENSIVE SYSTEMIC THERAPY (VOL 93, PG 15346, 1996)/
Authors: HANANIA EG GILES RE KAVANAGH J FU SQ ELLERSON D ZU Z WANG T SU Y KUDELKA A RAHMAN Z HOLMES F HORTOBAGYI G CLAXTON D BACHIER C THALL P CHENG S HESTER J OSTROVE JM BIRD RE CHANG A KORBLING M SEONG D COTE R HOLZMAYER T MECHETNER E HEIMFELD S BERENSON R BURTNESS B EDWARDS C BAST B ANDREEFF M CHAMPLIN R DEISSEROTH AB
Citation: Eg. Hanania et al., RESULTS OF MDR-1 VECTOR MODIFICATION TRIAL INDICATE THAT GRANULOCYTE MACROPHAGE COLONY-FORMING UNIT CELLS DO NOT CONTRIBUTE TO POSTTRANSPLANT HEMATOPOIETIC RECOVERY FOLLOWING INTENSIVE SYSTEMIC THERAPY (VOL 93, PG 15346, 1996)/, Proceedings of the National Academy of Sciences of the United Statesof America, 94(10), 1997, pp. 5495-5495
RESULTS OF MDR-1 VECTOR MODIFICATION TRIAL INDICATE THAT GRANULOCYTE MACROPHAGE COLONY-FORMING UNIT CELLS DO NOT CONTRIBUTE TO POSTTRANSPLANT HEMATOPOIETIC RECOVERY FOLLOWING INTENSIVE SYSTEMIC THERAPY/
Authors: HANANIA EG GILES RE KAVANAGH J ELLERSON D ZU Z WANG T SU Y KUDELKA A RAHMAN Z HOLMES F HORTOBAGYI G CLAXTON D BACHIER C THALL P CHENG S HESTER J OSTROVE JM BIRD RE CHANG A KORBLING M SEONG D COTE R HOLZMAYER T MECHETNER E HEIMFELD S BERENSON R BURTNESS B EDWARDS C BAST R ANDREEFF M CHAMPLIN R DEISSEROTH AB
Citation: Eg. Hanania et al., RESULTS OF MDR-1 VECTOR MODIFICATION TRIAL INDICATE THAT GRANULOCYTE MACROPHAGE COLONY-FORMING UNIT CELLS DO NOT CONTRIBUTE TO POSTTRANSPLANT HEMATOPOIETIC RECOVERY FOLLOWING INTENSIVE SYSTEMIC THERAPY/, Proceedings of the National Academy of Sciences of the United Statesof America, 93(26), 1996, pp. 15346-15351
GENETIC-MODIFICATION OF CELLS USED FOR TRANSPLANT FOLLOWING INTENSIVETHERAPY FOR OVARIAN-CANCER ANP BREAST-CANCER
Authors: KAVANAGH J HANANIA E GILES R FU SQ ZU Z ELLERSON D WANG T CLAXTON D RAHMAN Z BERENSON R HEIMFELD S COTE R HOLZMAYER T MECHETNER E DAYNE A ANDREEFF M CHAMPLIN R DEISSEROTH AB
Citation: J. Kavanagh et al., GENETIC-MODIFICATION OF CELLS USED FOR TRANSPLANT FOLLOWING INTENSIVETHERAPY FOR OVARIAN-CANCER ANP BREAST-CANCER, Blood, 88(10), 1996, pp. 1075-1075
MDR-1 VECTOR MARKING SHOWS THAT CFUGMS DO NOT CONTRIBUTE TO ENGRAFTMENT IN PATIENTS FOLLOWING INTENSIVE SYSTEMIC COMBINATION CHEMOTHERAPY
Authors: HANANIA E GILES R FU SQ ZU Z COTE R DAYN A WANG T ELLERSON D KAVANAGH J HOLZMAYER T MECHETNER E BERENSON R HEIMFELD S RAHMAN Z ANDREEFF M CHAMPLIN R DEISSEROTH AB
Citation: E. Hanania et al., MDR-1 VECTOR MARKING SHOWS THAT CFUGMS DO NOT CONTRIBUTE TO ENGRAFTMENT IN PATIENTS FOLLOWING INTENSIVE SYSTEMIC COMBINATION CHEMOTHERAPY, Blood, 88(10), 1996, pp. 2369-2369
CHEMOTHERAPY RESISTANCE TO TAXOL IN CLONOGENIC PROGENITOR CELLS FOLLOWING TRANSDUCTION OF CD34 SELECTED MARROW AND PERIPHERAL-BLOOD CELLS WITH A RETROVIRUS THAT CONTAINS THE MDR-1 CHEMOTHERAPY RESISTANCE GENE
Authors: HANANIA EG FU S ZU Z HEGEWISCHBECKER S KORBLING M HESTER J DURETT A ANDREEFF M MECHETNER E HOLZMAYER T RONINSON IB GILES RE BERENSON R HEIMFELD S DEISSEROTH AB
Citation: Eg. Hanania et al., CHEMOTHERAPY RESISTANCE TO TAXOL IN CLONOGENIC PROGENITOR CELLS FOLLOWING TRANSDUCTION OF CD34 SELECTED MARROW AND PERIPHERAL-BLOOD CELLS WITH A RETROVIRUS THAT CONTAINS THE MDR-1 CHEMOTHERAPY RESISTANCE GENE, Gene therapy, 2(4), 1995, pp. 285-294
RAPID NEUTROPHIL RECOVERY IN AUTOLOGOUS TRANSPLANTS USING CELLS THAT HAVE BEEN EXPOSED TO A MULTIPLE-DRUG RESISTANCE (MDR-1) RETROVIRAL VECTOR
Authors: HANANIA EG KAVANAGH J GILES RE KUDELKA A RAHMAN Z HOLMES F HORTOBAGYI G HAMER J CALVERT L FINNEGAN MB MANTE R ELLERSON D GEISLER D WANG T SU Y ZU Z CHEN N BERENSON R HEIMFELD S CLAXTON D MECHETNER E HOLZMAYER T MEHRA R COTE R CHAMPLIN R DEISSEROTH AB
Citation: Eg. Hanania et al., RAPID NEUTROPHIL RECOVERY IN AUTOLOGOUS TRANSPLANTS USING CELLS THAT HAVE BEEN EXPOSED TO A MULTIPLE-DRUG RESISTANCE (MDR-1) RETROVIRAL VECTOR, Blood, 86(10), 1995, pp. 1833-1833
Risultati: 1-9 |